Jiangsu Nhwa Pharmaceutical Co Ltd (002262) — Capital Reinvestment Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥425.83 Million) in capital expenditures (CN¥80.95 Million). See Jiangsu Nhwa Pharmaceutical Co Ltd (002262) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Nhwa Pharmaceutical Co Ltd Capital Reinvestment Ratio (2005–2025)
This chart tracks Jiangsu Nhwa Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 21 annual periods. Check 002262 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Year-by-year Capital Reinvestment Ratio for Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. For live market cap and broader valuation context, see Jiangsu Nhwa Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | CN¥1.08 Billion | CN¥437.41 Million | ▼ -17.4% |
| 2024 | 0.49x | CN¥916.13 Million | CN¥450.06 Million | ▲ +32.4% |
| 2023 | 0.37x | CN¥1.01 Billion | CN¥373.99 Million | ▼ -2.6% |
| 2022 | 0.38x | CN¥861.02 Million | CN¥327.75 Million | ▲ +29.5% |
| 2021 | 0.29x | CN¥701.12 Million | CN¥206.11 Million | ▲ +36.6% |
| 2020 | 0.22x | CN¥1.25 Billion | CN¥268.61 Million | ▼ -58.9% |
| 2019 | 0.52x | CN¥305.97 Million | CN¥160.30 Million | ▲ +24.2% |
| 2018 | 0.42x | CN¥404.52 Million | CN¥170.70 Million | ▲ +15.0% |
| 2017 | 0.37x | CN¥452.35 Million | CN¥166.01 Million | ▼ -0.5% |
| 2016 | 0.37x | CN¥277.14 Million | CN¥102.22 Million | ▼ -65.2% |
| 2015 | 1.06x | CN¥204.24 Million | CN¥216.63 Million | ▼ -35.0% |
| 2014 | 1.63x | CN¥160.24 Million | CN¥261.60 Million | ▲ +206.2% |
| 2013 | 0.53x | CN¥194.33 Million | CN¥103.63 Million | ▲ +5.4% |
| 2012 | 0.51x | CN¥154.16 Million | CN¥78.01 Million | ▼ -11.2% |
| 2011 | 0.57x | CN¥81.08 Million | CN¥46.21 Million | ▼ -58.8% |
| 2010 | 1.38x | CN¥61.79 Million | CN¥85.57 Million | ▲ +101.3% |
| 2009 | 0.69x | CN¥61.27 Million | CN¥42.15 Million | ▼ -14.5% |
| 2008 | 0.80x | CN¥46.50 Million | CN¥37.40 Million | ▼ -6.9% |
| 2007 | 0.86x | CN¥48.55 Million | CN¥41.96 Million | ▼ -25.8% |
| 2006 | 1.16x | CN¥30.99 Million | CN¥36.09 Million | ▼ -67.8% |
| 2005 | 3.62x | CN¥8.84 Million | CN¥31.99 Million | — |